ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/11/01 | 日証協 | 100,982株 | -6.1% | 69,848株 | -12.1% | 115,873株 | -2.33% | 21,100株 | -17.85% |
2024/10/25 | 日証協 | 107,538株 | -21.31% | 79,461株 | +3.04% | 118,642株 | -0.25% | 25,684株 | -12.64% |
2024/10/18 | 日証協 | 136,653株 | -2.72% | 77,114株 | -45.19% | 118,942株 | -2.46% | 29,399株 | -28.32% |
2024/10/11 | 日証協 | 140,473株 | -57.38% | 140,681株 | -17.1% | 121,943株 | -48.8% | 41,013株 | +55.18% |
2024/10/04 | 日証協 | 329,610株 | -1.34% | 169,706株 | +34.33% | 238,167株 | -2.7% | 26,430株 | +20.68% |
2024/09/27 | 日証協 | 334,084株 | +4.74% | 126,332株 | -14.86% | 244,786株 | +3.69% | 21,901株 | +94.33% |
2024/09/20 | 日証協 | 318,974株 | +0.48% | 148,390株 | -26% | 236,086株 | +1.17% | 11,270株 | -25.37% |
2024/09/13 | 日証協 | 317,453株 | -0.8% | 200,523株 | +96.61% | 233,367株 | -0.8% | 15,101株 | -20.14% |
2024/09/06 | 日証協 | 319,999株 | +0.72% | 101,988株 | -54.9% | 235,249株 | -2.04% | 18,909株 | -4.95% |
2024/08/30 | 日証協 | 317,719株 | +5.65% | 226,158株 | +95.75% | 240,144株 | -1.44% | 19,894株 | +7.49% |
2024/08/23 | 日証協 | 300,739株 | +2.58% | 115,533株 | -43.02% | 243,653株 | +4.46% | 18,508株 | -76.02% |
2024/08/16 | 日証協 | 293,161株 | -8.96% | 202,776株 | -20.8% | 233,243株 | -1.81% | 77,181株 | +58.07% |
2024/08/09 | 日証協 | 322,020株 | -22.55% | 256,046株 | +359.89% | 237,543株 | -21.9% | 48,828株 | -16.69% |
2024/08/02 | 日証協 | 415,797株 | +3.35% | 55,675株 | +6.43% | 304,143株 | -4.04% | 58,609株 | +129.43% |
2024/07/26 | 日証協 | 402,318株 | -5.22% | 52,309株 | -86.93% | 316,943株 | -6.82% | 25,546株 | -85.51% |
2024/07/19 | 日証協 | 424,486株 | +24.86% | 400,222株 | +154.78% | 340,143株 | +24.39% | 176,253株 | +122.87% |
2024/07/12 | 日証協 | 339,972株 | +11.01% | 157,087株 | -31.45% | 273,443株 | -1.33% | 79,084株 | +462.56% |
2024/07/05 | 日証協 | 306,255株 | +11.4% | 229,168株 | +77.22% | 277,133株 | +3.71% | 14,058株 | -56.92% |
2024/06/28 | 日証協 | 274,903株 | +11.27% | 129,310株 | -28.82% | 267,219株 | +3.49% | 32,634株 | -13.14% |
※株式分割は考慮していませんのでご注意ください。
Page Top